Aqua Bio Technology (OSL: ABTEC) revenue
Aqua Bio Technology reported revenue of NOK 1.3m for fiscal 2025, 98.7% less than in fiscal 2024 (NOK 106.6m). Since fiscal 2020 its revenue has grown by 201.3%, an average growth of 24.7% a year.
Aqua Bio Technology's best year of the last 6 was fiscal 2024. The biggest drop was in fiscal 2025, −98.7%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | NOK 1.3m | −98.7% | −NOK 11.7m | −871.4% |
| 2024 | NOK 106.6m | +478.9% | −NOK 325.7m | −305.7% |
| 2023 | NOK 18.4m | +162.3% | −NOK 15.8m | −85.8% |
| 2022 | NOK 7.0m | +349.9% | −NOK 16.4m | −233.3% |
| 2021 | NOK 1.6m | +251.0% | −NOK 17.9m | −1,144.9% |
| 2020 | NOK 0.4m | — | −NOK 16.1m | −3,624.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Norwegian kroner, except per-share amounts.
Aqua Bio Technology revenue compared with its sector
By revenue for its latest fiscal year, Aqua Bio Technology ranks 58th of the 59 Spanish and European health care companies with a page on Celsmar. The sector median grew 4.5% in its latest fiscal year; Aqua Bio Technology, −98.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 55th | OSE Immunotherapeutics | €2.6m | — |
| 56th | Adocia | €1.5m | −84.2% |
| 57th | Transgene | €0.1m | 291.4% |
| 58th | Aqua Bio Technology | NOK 1.3m | −98.7% |
| 59th | Carvolix | €0.0m | −100.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in health care stocks.
Questions about the revenue of Aqua Bio Technology
- How much revenue did Aqua Bio Technology make in fiscal 2025?
- Aqua Bio Technology reported revenue of NOK 1.3m for fiscal 2025, compared with NOK 106.6m in fiscal 2024.
- How much has the revenue of Aqua Bio Technology grown?
- Between fiscal 2020 and fiscal 2025 it went from NOK 0.4m to NOK 1.3m: 201.3% more, an average growth of 24.7% a year.
- What was the best year for revenue at Aqua Bio Technology?
- Of its last 6 fiscal years, fiscal 2024, with NOK 106.6m.
- Where does Aqua Bio Technology rank in its sector by revenue?
- It ranks 58th of the 59 Spanish and European health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Aqua Bio Technology come from?
- From the report Aqua Bio Technology files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
From the annual report Aqua Bio Technology files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Aqua Bio Technology: the Aqua Bio Technology page · annual accounts · net income.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.